**Core Concept**
Alpha-2 adrenergic agonists are a class of medications used in the management of glaucoma. They decrease intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow. This class of medications works by stimulating alpha-2 adrenergic receptors in the ciliary body, leading to a decrease in aqueous humor production.

**Why the Correct Answer is Right**
The correct answer is **B. Brimonidine**. Brimonidine is an alpha-2 adrenergic agonist that works by stimulating alpha-2 adrenergic receptors in the ciliary body, leading to a decrease in aqueous humor production. This results in a decrease in intraocular pressure, making it an effective treatment for glaucoma. Brimonidine also has a mild vasoconstrictive effect on the conjunctiva and episclera, which may contribute to its effectiveness in reducing intraocular pressure.

**Why Each Wrong Option is Incorrect**
**Option A:** **Apraclonidine** is another alpha-2 adrenergic agonist, but it is not the most commonly used or preferred medication for glaucoma treatment.
**Option C:** **Doxazosin** is an alpha-1 adrenergic antagonist, which is actually used to treat benign prostatic hyperplasia and hypertension, not glaucoma.
**Option D:** **Dipivefrine** is a prodrug of epinephrine, which is actually a beta-adrenergic agonist, not an alpha-2 adrenergic agonist.

**Clinical Pearl / High-Yield Fact**
Alpha-2 adrenergic agonists like Brimonidine are often used in combination with other medications to achieve optimal intraocular pressure control in patients with glaucoma. This is because they have a synergistic effect when used with other classes of medications.

**Correct Answer: B. Brimonidine**